Pharmaceutical

Our client was the widow of a gentleman who was prescribed Propulsid manufactured by Johnson & Johnson and Janssen Pharmaceutica for treatment of esophageal reflux. After taking the prescription medication for only eight days, our client’s husband suffered a terminal cardiac arrhythmia. Fourteen months after the death of our client’s husband, the defendant pharmaceutical companies ordered the medication to be discontinued.

Outcome:

This case settled prior to trial for a confidential amount.